Amir Kalali Archives - Page 2 of 0 - Innovations in Clinical Neuroscience

Editor’s Message—Issue Highlights, July–August 2016

Dear Colleagues: Welcome to the July–August 2016 issue of Innovations in Clinical Neuroscience. We start this issue with an interesting study by MacEwan et al titled, “Pharmaceutical Innovation in the

Editor’s Message and January-February 2015 Issue Highlights

Dear Colleagues: Welcome to the January-February 2015 issue of Innovations in Clinical Neuroscience and to the beginning of our 12th year of publication. Over the years, we have sought to

Editor’s Message and Issue Highlights, July–August 2014

Dear Colleagues: Welcome to the July-August issue of Innovations in Clinical Neuroscience. We start this issue with an original research article titled, “Transcultural Adaptation of GRID Hamilton Rating Scale For

September-October 2013 Issue Highlights and Editorial Message

Dear Colleagues: Welcome to the September–October issue of Innovations in Clinical Neuroscience. We start with a study by El-Ibiary et al titled, “A Pilot Study Evaluating Genetic and Environmental Factors

July-August 2013 Issue Highlights and Editorial Message

Dear Colleagues: Welcome to the July–August 2013 issue of Innovations in Clinical Neuroscience.

Editor’s Message: Issue Highlights, May–June 2013

Dear Colleagues: Welcome to the May–June 2013 issue of Innovations in Clinical Neuroscience.

Editor’s Message and Issue Highlights, April 2013

Dear Colleagues: Welcome to the April issue of Innovations in Clinical Neuroscience. This month, we lead with a topic we are covering for the first time in the journal and

March 2013 Issue Highlights and Editor’s Message

Dear Colleagues: Welcome to the March 2013 issue of Innovations in Clinical Neuroscience. We start this issue with a study by Vilhauer et al titled, “Improving Quality of Life for

Editor’s Message and Issue Highlights—February 2013

Welcome to the February issue of Innovations in Clinical Neuroscience. We start this issue with a study by Shiovitz et al in which the authors report the results of the

Issue Highlights, September 2012

Dear Colleagues: Welcome to the September issue of Innovations in Clinical Neuroscience. In this issue, we are pleased to present

Editorial Message and Issue Highlights—July–August 2012 Issue

Dear Colleagues: Welcome to the July-August issue of Innovations in Clinical Neuroscience. We hope everyone enjoyed a relaxing summer spent with family and friends. We start this issue of the

May-June Issue Highlights

Dear Colleagues: Welcome to the May-June issue of Innovations in Clinical Innovations. In this issue of the journal, we start with two articles on adult attention deficit hyperactivity disorder (ADHD).

Editor’s Message and Issue Highlights, April 2012

Dear Colleagues: Welcome to the April issue of Innovations in Clinical Neuroscience. In this issue, we offer two interesting articles that touch on schizophrenia. In a review article by

Editorial Message and Issue Highlights

Dear Colleagues: Welcome to the March issue of Innovations in Clinical Neuroscience. Innovation in neuroscience may not always be demonstrated in the creation of a novel drug or technologically advanced

Issue Highlights, March 2011

Dear Colleagues: Welcome to the March issue of Innovations in Clinical Neuroscience.

Editor’s Message and Issue Highlights

Dear Colleagues: Welcome to the February 2011 issue of Innovations in Clinical Neuroscience.

Welcome to the January issue!

Dear Colleagues: Welcome to the January issue of Innovations in Clinical Neuroscience, our first issue under our new title. We have a diverse issue this month, and we hope you

The Evolution of a Journal

Dear Colleagues: Welcome to the December issue of Psychiatry 2010. We hope you all are enjoying the holiday season and are looking forward to a healthy, happy 2011. As you

A Review of New Atypical Antipsychotic Launches in the United States

by Jeff Ventimiglia, BSE; Amir H. Kalali, MD; and Leslie Citrome, MD, MPH Mr. Ventimiglia is a Senior Analyst in Clinical Development Services, Quintiles, Inc., Durham, North Carolina; Dr. Kalali

Journal Name Change in 2011

Starting with the January 2011 issue (Volume 8, Number 1), Psychiatry 2010 will now be called Innovations in Clinical Neuroscience. We believe this title better reflects the journal’s content, while

Welcome to the November issue of Psychiatry 2010

Dear Colleagues: Welcome to the November issue of Psychiatry 2010.

An Analysis of the Intended Use of Atypical Antipsychotics in Dementia

by Jeff Ventimiglia, BSE; Amir H. Kalali, MD; Ipsit V. Vahia, MD; and Dilip V. Jeste, MD Mr. Ventimiglia is an analyst in Clinical Strategy and Solutions, Quintiles, Inc., in

Welcome to the October issue of Psychiatry 2010

Welcome to the August issue of Psychiatry 2010

Welcome to the July issue of Psychiatry 2010

Dear Colleagues: Welcome to the July issue of Psychiatry 2010. We start this issue with Trend Watch, in which the authors provide information on patient-reported side effects from a cross-section

Real-world Data on Atypical Antipsychotic Medication Side Effects

by Elisa Cascade; Amir H. Kalali, MD; Sagar Mehra; and Jonathan M. Meyer, MD Ms. Cascade is Vice President, Quintiles Inc./iGuard, Falls Church, Virginia; Dr. Kalali is Vice President, Global

Editor’s Message–June Issue Highlights

March 2010 Issue Highlights

Dear Colleagues: Welcome to the March issue of Psychiatry 2010. In this month’s “Trend Watch,” the authors explore the penetration of generic atypical antipsychotics in the United States market before

DIGITAL EDITION

ARCHIVES

Tag: Amir Kalali